An open randomised non comparative phase II trial of docetaxel (taxotere) in combination with ZD1839 (Iressa) and docetaxel alone as second line chemotherapy in patients with advanced or metastatic non small cell lung cancer

Study identifier:1839IL/0137

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An open randomised non comparative phase II trial of docetaxel (taxotere) in combination with ZD1839 (Iressa) and docetaxel alone as second line chemotherapy in patients with advanced or metastatic non small cell lung cancer

Medical condition

lung cancer

Phase

Phase 2

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 May 2003
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria